IP Library Granted Patent US 10,086,081
Granted Patent B2
US 10,086,081 · App. 14/420,189 · Granted Oct 2, 2018

Carbohydrate conjugated RNA agents and process for their preparation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,086,081
App. No.
14/420,189
Granted
Oct 2, 2018
Kind
B2
Abstract

This disclosure relates to an improved process for the preparation of carbohydrate conjugates. The disclosure also relates to carbohydrate conjugated iRNA agents comprising these carbohydrate conjugates, which have improved purity and are advantageous for the in vivo delivery of the iRNA agents.

Claims (92)

1. A process for preparing a compound of formula (A):

wherein

each occurrence of X is hydrogen or a hydroxy protecting group;

each occurrence of Y is an amine protecting group;

n is 0-20;

each occurrence of q, r and s is independently 1-7;

L is a linking group; and

R 1 is an iRNA agent;

the process comprising

(a) converting a compound of formula (VI) to a compound of formula (VII):

by a process comprising:

(i) reacting the compound of formula (VI) with a base;

(ii) reducing the product of step (i); and

(iii) reacting the product of step (ii) with an acid; and

(b) converting the compound of formula (VII) to a compound of formula (A);

wherein the compound of formula (A) is free or substantially free of one or more of

(i) metal impurities,

(ii) each of the following two urea side products

 and

(iii) each of the following saccharide compounds

2. The process of claim 1 , wherein the base is a metal alkoxide.

3. The process of claim 1 , wherein the base is sodium methoxide, step (ii) involves reacting the product of step (i) with sodium borohydride, and the acid is hydrochloric acid.

4. A process for preparing a compound of formula (A):

wherein

each occurrence of X is hydrogen or a hydroxy protecting group;

each occurrence of Y is an amine protecting group;

n is 0-20;

each occurrence of q, r and s is independently 1-7;

L is a linking group; and

R 1 is an iRNA agent;

the process comprising

(a) reacting a compound of the formula (IX):

with a compound of the formula (X):

wherein Hal is halogen to yield a compound of formula (VIII)

wherein

A is a C 6 -C 14 alkylene linker;

each R is, independently, an acid protecting group; and

R x is an acid protecting group; and

(b) converting the compound of formula (VIII) to a compound of formula (A);

wherein the compound of formula (A) is free or substantially free of one or more of

(i) metal impurities,

(ii) each of the following two urea side products

 and

(iii) each of the following saccharide compounds

5. The process of claim 4 , wherein R is t-butyl, Hal is Cl and A is a C 10 alkylene linker.

6. The process of claim 4 , wherein the reaction is conducted in the presence of N,N-diisopropylethylamine.

7. A process for preparing a compound of formula (A):

wherein

each occurrence of X is hydrogen or a hydroxy protecting group;

each occurrence of Y is an amine protecting group;

n is 0-20;

each occurrence of q, r and s is independently 1-7;

L is a linking group; and

R 1 is an iRNA agent;

the process comprising:

a) reacting a compound of the formula (XII):

wherein P is an amino protecting group with a sulfonic acid to give a compound of formula (II):

wherein

Z is an acid protecting group,

n is 0-20, and

each occurrence of q, r and s is independently 1-7; and

b) converting the compound of formula (II) to a compound of formula (A);

wherein the compound of formula (A) is free or substantially free of one or more of

(i) metal impurities,

(ii) each of the following two urea side products

 and

(iii) each of the following saccharide compounds

8. The process of claim 7 , wherein the sulfonic acid is p-toluene sulfonic acid or methanesulfonic acid.

9. A process for preparing a compound of formula (A):

wherein

each occurrence of X is hydrogen or a hydroxy protecting group;

each occurrence of Y is an amine protecting group;

n is 0-20;

each occurrence of q, r and s is independently 1-7;

L is a linking group; and

R 1 is an iRNA agent;

the process comprising:

a) reacting a compound of formula (XIV)

with dihydrofuran-2,5-dione in the presence of a tertiary amine to give a compound of formula (XIII):

wherein

X is a hydroxyl protecting group;

Y is an amine protecting group;

Prt is a hydroxyl protecting group;

n is 0-15; and

q, r and s are each, independently, 1-7; and

b) converting the compound of formula (XIII) to a compound of formula (A);

wherein the compound of formula (A) is free or substantially free of one or more of

(i) metal impurities,

(ii) each of the following two urea side products

 and

(iii) each of the following saccharide compounds

10. The process of claim 9 , wherein the tertiary amine is triethylamine or pyridine.

Assignments (2)
SECURITY INTEREST Recorded Oct 1, 2025
From: ALNYLAM PHARMACEUTICALS, INC.; SIRNA THERAPEUTICS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 072996/0337 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2016
From: NAIR, JAYAPRAKASH K; KELIN, ALEXANDER V; KANDASAMY, PACHAMUTHU; RAJEEV, KALLANTHOTTATHIL G; MANOHARAN, MUTHIAH
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 039248/0012 →